Antithrombotic therapies. anticoagulation and thrombolysis.

Ruchika Goel, Suresh Vedantham, Neil A. Goldenberg

Research output: Contribution to journalReview articlepeer-review

Abstract

Pediatric deep vein thrombosis is an increasingly recognized phenomenon, especially with advances in treatment and supportive care of critically ill children and with better diagnostic capabilities. High-quality evidence and uniform management guidelines for antithrombotic treatment, particularly thrombolytic therapy, remain limited. Optimal dosing, intensity and duration strategies for anticoagulation as well as thrombolytic regimens that maximize efficacy and safety need to be determined through well-designed clinical trials using use of a risk-stratified approach.

Original languageEnglish (US)
Pages (from-to)1463-1474
Number of pages12
JournalPediatric clinics of North America
Volume60
Issue number6
DOIs
StatePublished - Dec 2013

Keywords

  • Anticoagulant
  • Deep vein thrombosis
  • Pediatrics
  • Thrombolysis
  • Venous thromboembolism

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Antithrombotic therapies. anticoagulation and thrombolysis.'. Together they form a unique fingerprint.

Cite this